Compare TRIP & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIP | INSP |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2011 | 2018 |
| Metric | TRIP | INSP |
|---|---|---|
| Price | $12.83 | $42.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $14.40 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 4.5M | 854.5K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 675.00 | 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,556,000,000.00 | $82,050,000.00 |
| Revenue This Year | $3.33 | $8.02 |
| Revenue Next Year | $5.12 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $9.01 | $38.91 |
| 52 Week High | $20.16 | $147.03 |
| Indicator | TRIP | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 49.35 |
| Support Level | $12.11 | $39.26 |
| Resistance Level | $13.88 | $44.75 |
| Average True Range (ATR) | 0.68 | 1.96 |
| MACD | 0.05 | 0.44 |
| Stochastic Oscillator | 54.39 | 67.71 |
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.